Photo: isbtweb.org
Mar 3, 2026, 14:21
Webinar on CAR-T Cells – Heterogeneity, Quality Control, and Adverse Events – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“ISBT Webinar: Let’s talk CAR-T cells – heterogeneity, quality control and adverse events.
4 March 2026 | 17:00–18:00 CET
Join Oulghazi Salim for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.
Ideal for scientists, transfusion professionals, MDs, and MSc/PhD students.
Register now and be part of the conversation”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 13:56ASPERA-R Study Investigates Anticoagulation Timing Following Breakthrough Ischemic Stroke – International Journal of Stroke
-
Nov 14, 2026, 13:47Karen A. Moffat: New 2026 Issue on Laboratory Diagnostics in Thrombosis and Haemostasis
-
Nov 14, 2026, 13:45César Erazo: Investigating Anticoagulation in Secondary Stroke Prevention at AHA 2026
-
Nov 14, 2026, 13:41Hussein Abdelwahab: FDA Approves Asundexian as the First Factor XIa Inhibitor for Stroke Prevention
-
Nov 14, 2026, 13:31John Augoustides: Practical Anticoagulation Strategies for Cardiopulmonary Bypass in Patients with HIT
-
Nov 14, 2026, 13:09Antonio Galante: Management of Portal Vein Thrombosis
-
Nov 14, 2026, 12:47Yasmin Mohtasham Kia: Anticoagulation Knowledge and Treatment Outcomes in Patients With Mechanical Heart Valves
-
Nov 14, 2026, 12:37Nathan Connell: Annualized Bleeding Rate and the Future of Hemophilia A Treatment
-
Nov 14, 2026, 12:3210 Posts Not to Miss This Week